Lillys spending on R&D has more than doubled in the previous five years, jumping from $6.1 billion in spending in 2020, to an expected $13.3 billion in 2025 (based on FactSet consensus estimates as of 11/21/2025)
We offer free FDA approval, free label design, and free shipping for our clients
Three participants prematurely withdrawn reported an AE related to a gastrointestinal disorder (lipase increase, nausea, constipation), a known class effect for GLP-1 agonists
Although Ozempic, Trulicity, and other GLP-1 drugs have long been used for type 2 diabetes management, the approval of specific GLP-1 agonists for weight loss purposes in the United States has put them back in the spotlight
Can be used for: All skin types
Clinical studies consistently demonstrate that semaglutide offers superior results compared to other GLP-1 receptor agonists, such as liraglutide